Antithrombosis stewardship across the care spectrum: optimizing transitions in venous thromboembolism.

As global burden of venous thromboembolism (VTE) increases, clinicians are managing more patients across diverse and often fragmented care settings. VTE care transitions are more frequent and complex than those seen in stable anticoagulation conditions like atrial fibrillation. Each transition presents opportunity for optimizing antithrombotic therapies and mitigating associated risks. In this review, we use case-based scenarios to highlight common care transition challenges and offer evidence-based, stewardship-guided strategies to optimize antithrombotic use and outcomes throughout the VTE continuum.